Remove Drug Delivery Remove Gene Editing Remove Genome
article thumbnail

Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics

The Pharma Data

Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Financial details were not disclosed.

article thumbnail

Rheumatoid arthritis treated with implanted cells that release drug

The Pharma Data

The approach allows those cells to remain in the body for a long time and secrete a drug whenever there is a flare of inflammation.” The researchers used CRISPR-Cas9 genome editing technology to make cells that secrete a biologic drug in response to inflammation. ” The new findings are published online Sept.

Drugs 52
article thumbnail

Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

Delveinsight

Beam adds to drug delivery stable with USD 120 Million GuideTx buy. The gene-editing technologies, which have reached the clinic, CRISPR, zinc finger nucleases, and TALENs, make their edits by nicking DNA at the target site.

DNA 52